Email This Article
Arthritis Drugs Put a Hurt on Merck and Pfizer
By
Robert Steyer
10/07/04 - 03:14 PM EDT
Shareholders continue to feel the pain as questions persist in the wake of the Vioxx recall.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Find more premium investing ideas